CD263 (TRAIL-R3) Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA123498-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA123498 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
CD263 (TRAIL-R3)
Classification
Polyclonal
Conjugate
Unconjugated
Gene
TNFRSF10C
Gene Alias
Antagonist decoy receptor for TRAIL/Apo-2L; CD263; cytotoxic TRAIL receptor-3; DCR1; DCR1-TNFR; Decoy receptor 1; decoy TRAIL receptor without death domain; LIT; lymphocyte inhibitor of TRAIL; MGC149501; MGC149502; TNF receptor superfamily member 10c; TNF-related apoptosis-inducing ligand receptor 3; TNFRSF10C; TRAIL receptor 3; TRAIL receptor without an intracellular domain; TRAILR3; TRAIL-R3; TRID; Tumor necrosis factor receptor superfamily member 10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; UNQ321/PRO366
Host Species
Rabbit
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Applications
ELISA, Western Blot
Concentration
Conc. Not Determined
Formulation
whole serum with 0.02% sodium azide
Gene Accession No.
O14798
Gene Symbols
TNFRSF10C
Immunogen
Rabbit Polyclonal to TRAIL - Receptor 3 ( TRAIL - R3 )
Regulatory Status
RUO
Gene ID (Entrez)
8794
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- Description PA1-23498 detects TRAIL-Receptor 3 in Human samples
- TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily
- This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain
- This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis
- This gene was found to be a p53-regulated DNA damage-inducible gene
- The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.